We are live on ! Find out more
ENSC icon

Ensysce Biosciences
ENSC

15 hedge funds and large institutions have $9.56M invested in Ensysce Biosciences in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HVCM
HG Vora Capital Management
New York
+$13.4M
2
Stifel Financial
Stifel Financial
Missouri
+$1.76M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$293K
4
Millennium Management
Millennium Management
New York
+$215K
5
FIA
FNY Investment Advisers
New York
+$176K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HVCM
1
HG Vora Capital Management
New York
$7.46M +$13.4M +684 New
Stifel Financial
2
Stifel Financial
Missouri
$980K +$1.76M +90 New
FFIM
3
Founders Fund III Management
California
$435K +$782K +40 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$166K +$293K +15 New
Millennium Management
5
Millennium Management
New York
$115K +$215K +11 New
FIA
6
FNY Investment Advisers
New York
$103K +$176K +9 New
VF
7
Virtu Financial
New York
$78K +$137K +7 New
ECM
8
Evergreen Capital Management
Washington
$43K +$78.2K +4 New
CAM
9
Cresset Asset Management
Illinois
$42K +$78.2K +4 New
Jane Street
10
Jane Street
New York
$38K +$58.6K +3 New
TSS
11
Two Sigma Securities
New York
$34K +$58.6K +3 New
TRCT
12
Tower Research Capital (TRC)
New York
$32K +$58.6K +3 New
CCM
13
Covington Capital Management
California
$15K +$19.5K +1 New
Morgan Stanley
14
Morgan Stanley
New York
$10K +$19.5K +1 New
WAM
15
Wolverine Asset Management
Illinois
$8K +$19.5K +1 New

ENSC Hedge Fund Activity: Q3 2021 in Review

15 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ensysce Biosciences (ENSC) for Q3 2021, worth a combined $9.56M.

Buyers outnumbered sellers: 15 funds opened new ENSC positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was HG Vora Capital Management, opening a new position worth an estimated $13.4M.

  • 15 institutional investors held Ensysce Biosciences (ENSC) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $9.56M of Ensysce Biosciences stock for Q3 2021.
  • 15 funds opened new Ensysce Biosciences positions in Q3 2021 and 0 closed out, a net change of +15 holders.
  • The largest Ensysce Biosciences buyer in Q3 2021 was HG Vora Capital Management, an estimated $13.4M added.

Based on aggregated 13F filings for Q3 2021.